SALKA SUSAN R

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-057308 · doc4.xml · derivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,717

Underlying: Common Stock · 30,717 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units (RSUs) reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs reflected in this row were granted on September 20, 2021 and vest on the first, second and third anniversary of the grant date.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001598100-21-000044 · edgar.xml · derivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 889

Underlying: Common Stock · 889 shares

Expires not disclosed

F2 · derivative.exercise_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

F2 · derivative.expiration_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

SEC source: 0001209191-21-071319 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,750

F7 · kind: The reporting person transferred 6,247 shares of AMN Common Stock as a gift to charity.

F8 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-014001 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,997

F1 · kind: The sale of 2,726 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $73.105396 per share. These shares were sold in multiple transactions at prices ranging from $72.22 to $73.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,723

F3 · kind: The sale of 14,882 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $71.276916 per share. These shares were sold in multiple transactions at prices ranging from $69.68 to $72.085, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F5 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,605

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,470

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2018. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2017 for the 3-year period beginning on January 1, 2018 and ended December 31, 2020 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2021. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F3 · kind: The sale of 8,301 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $68.040864 per share. These shares were sold in multiple transactions at prices ranging from $67.10 to $68.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F5 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-20-064891 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,687 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The RSUs were granted on December 19, 2017 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,597

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F4 · kind: The sale of 8,593 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $68.326843 per share. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F4 · kind: The sale of 8,593 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $68.326843 per share. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 9

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,543

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs reflected in this row were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,889

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 9

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,543

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs reflected in this row were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,889

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,906

Underlying: Common Stock · 6,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F11 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,882

Underlying: Common Stock · 18,882 shares

Expires not disclosed

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2020 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,449

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,906

Underlying: Common Stock · 6,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,625

Underlying: Common Stock · 19,625 shares

Expires not disclosed

F8 · security: Due to an administrative error, the Form 4 filed by the Reporting Person on December 18, 2020 understated the number of RSUs granted on December 16, 2020. This Form 4 is being amended and restated to reflect that 19,625 RSUs were granted on December 16, 2020, and not the 18,882 RSUs previously reported.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2020 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,449

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F6 · kind: The reporting person transferred 20,000 shares of AMN Common Stock as a gift to charity.

F7 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F6 · kind: The reporting person transferred 20,000 shares of AMN Common Stock as a gift to charity.

F7 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-20-063020 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F1 · kind: The sale of 5,988 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $68.667068 per share. These shares were sold in multiple transactions at prices ranging from $68.335 to $69.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-046554 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,284

F2 · kind: The sale of 19,800 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in this row represents a weighted average price of $53.003165 per share. These shares were sold in multiple transactions at prices ranging from $52.756 to $54.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-046554 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,084

F1 · kind: The reporting person transferred 690 shares of AMN Common Stock as a gift to charity.

SEC source: 0001598100-20-000042 · edgar.xml · derivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,157

Underlying: Common Stock · 1,157 shares

Expires not disclosed

F2 · derivative.exercise_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

F2 · derivative.expiration_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

SEC source: 0001209191-20-031668 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,774

F1 · kind: The sale of 29,168 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-020608 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,942

F1 · kind: The sale of 14,929 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $79.703087 per share. These shares were sold in multiple transactions at prices ranging from $67.52 to $89.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-010016 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,871

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-010016 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,641

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2019 for the one-year period beginning on January 1, 2019 and ended December 31, 2019. As a result, 25% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-003011 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,145

F1 · kind: The sale of 32,721 shares reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $62.0466 per share. These shares were sold in multiple transactions at prices ranging from $61.75 to 62.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-002443 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,866

F2 · kind: Number of shares withheld for tax purposes

SEC source: 0001209191-20-002443 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,685

F1 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2016 for the 3-year period beginning on January 1, 2017 and ended December 31, 2019 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 6, 2020. The Company's Relative TSR measured in the 81st percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-19-061066 · doc4.xml · derivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-19-061066 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,984

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-061066 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,865

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-19-061066 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,755

Underlying: Common Stock · 20,755 shares

Expires not disclosed

F3 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-18-061946 · doc4.xml · derivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,042 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Deferred Restricted Stock Units ("RSUs") identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Receipt of each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs were granted on December 9, 2015 and vest on the third anniversary of the grant date. Pursuant to the Reporting Person's irrevocable election, the RSUs will settle upon her separation of service from the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-059660 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units were granted on December 5, 2016 and vest on the third anniversary of the grant date.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,543

F3 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,555

F1 · kind: The reporting person transferred 8,000 shares of AMN Common Stock as a gift to charity.